Tenet Healthcare Corporation $THC Shares Purchased by Algert Global LLC

Algert Global LLC raised its position in Tenet Healthcare Corporation (NYSE:THC) by 21.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 50,379 shares of the company’s stock after purchasing an additional 9,000 shares during the quarter. Algert Global LLC owned about 0.06% of Tenet Healthcare worth $10,229,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in THC. WCM Investment Management LLC increased its position in shares of Tenet Healthcare by 244.4% during the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after purchasing an additional 362,083 shares during the last quarter. AlphaQuest LLC boosted its position in shares of Tenet Healthcare by 238.3% during the 3rd quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock worth $1,211,000 after purchasing an additional 4,202 shares during the period. Winnow Wealth LLC acquired a new stake in Tenet Healthcare in the 3rd quarter valued at approximately $1,129,000. Cerity Partners LLC lifted its stake in Tenet Healthcare by 10.4% during the second quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after purchasing an additional 11,395 shares in the last quarter. Finally, Savant Capital LLC boosted its position in shares of Tenet Healthcare by 27.5% during the third quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock worth $3,430,000 after buying an additional 3,647 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

THC has been the subject of a number of research analyst reports. Barclays raised their target price on Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a report on Friday, February 13th. UBS Group lifted their price objective on shares of Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. KeyCorp raised their price target on shares of Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a research report on Thursday, February 12th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $260.00 price objective on shares of Tenet Healthcare in a research report on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and an average target price of $250.56.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 24,000 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the sale, the executive vice president owned 8,012 shares of the company’s stock, valued at approximately $1,875,128.48. This trade represents a 74.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 46,517 shares of company stock worth $10,943,111 over the last three months. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Performance

NYSE:THC opened at $227.79 on Monday. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $247.21. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The firm has a market capitalization of $19.81 billion, a PE ratio of 14.71, a price-to-earnings-growth ratio of 1.10 and a beta of 1.39. The business’s fifty day moving average price is $213.46 and its 200 day moving average price is $204.31.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. During the same period in the prior year, the firm posted $3.44 EPS. The business’s quarterly revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, sell-side analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.